NVO-US: A Turning Point? Market Overreaction or GLP-1 Myth Come to an End?
Zhitong Caifu APP has learned that Danish pharmaceutical giant Novo Nordisk (NVO.US) plummeted nearly 30% in recent days, sparking market shockwaves, with its year-to-date decline exceeding 60%. This